mTor inhibitors.
mTOR inhibitors.
[mTOR inhibitors].
The neurology of mTOR.
Inhibitors of mTOR.
mTOR Signaling.
[mTOR inhibitor].
Staining of mTOR and phosphorylated-mTOR (p-mTOR) was documented and determined as percentage of the maximum.
mTOR and phosphorylated-mTOR (p-mTOR) expressions were investigated by immunohistochemistry.
mTOR pathway and mTOR inhibitors as agents for cancer therapy.
Dissecting the role of mTOR: lessons from mTOR inhibitors.
mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer.
mTOR signaling pathway and mTOR inhibitors in cancer therapy.
Roles of mTOR and p-mTOR in gastrointestinal stromal tumors.
p-mTOR expressions strongly correlate with mTOR expressions.
[mTOR and FTY 720 inhibitors].
mTOR inhibitors: an overview.
mTOR as a target for cancer therapy.
Growing roles for the mTOR pathway.
Upstream and downstream of mTOR.
mTOR inhibitors in hematologic malignancies.
mTOR signaling to translation.
The pleiotropic effects of mTor inhibitors.
An expanding role for mTOR in cancer.
mTOR: a mediator of intracellular homeostasis.
Kinase activities associated with mTOR.
Targeting mTOR for cancer treatment.
Sirolimus, the first mTOR inhibitor.
The mammalian target of rapamycin (mTOR).
AKT and cancer--is it all mTOR?
mTOR--beyond transplantation.
mTOR: the mammalian target of replication.
A focus is delivered for mTOR inhibitors.
mTOR and cancer therapy.
Regulation of mTOR by phosphatidic acid?
mTOR inhibitors and unilateral edema.
mTOR inhibitors in the treatment of cancer.
mTOR, translation initiation and cancer.
mTOR signalling in human cancer.
The mTOR pathway in breast cancer.
mTOR inhibitors in ADPKD.
On the participation of mTOR in recognition memory.
PTEN/mTOR and axon regeneration.
Inhibition of mTOR in kidney cancer.
mTOR goes to the nucleus.
SnapShot: mTOR signaling.
Rapamycin and mTOR kinase inhibitors.
mTOR, cancer and transplantation.
mTOR-what does it do?
Immunoregulatory functions of mTOR inhibition.
Expanding mTOR signaling.
Defining the role of mTOR in cancer.
mTOR-understanding the clinical effects.
The pharmacology of mTOR inhibition.
Targeting mTOR for cancer treatment.
The role of mTOR in bladder cancer.
Decision-making by p53 and mTOR.
Drug essentials mTOR inhibitors.
mTOR signaling at a glance.
The multiple facets of mTOR in immunity.
Updates of mTOR inhibitors.
Functional consequences of mTOR inhibition.
mTOR Signalling in Health and Disease.
Key factors in mTOR regulation.
mTOR, autophagy, and reprogramming.
Akt/mTOR signalling in myelination.
Deconvoluting mTOR biology.
The mTOR pathway in hepatic malignancies.
Where is mTOR and what is it doing there?
Modulating mTOR in aging and health.
The Paradox of Akt-mTOR Interactions.
mTOR expression in colorectal adenoma.
Senescence regulation by mTOR.
mTOR in aging, metabolism, and cancer.
mTOR: more targets of resveratrol?
FKBPs and the Akt/mTOR pathway.
mTOR and lymphocyte metabolism.
The functions of mTOR in ischemic diseases.
mTOR activity under hypoxia.
TFEBulous control of traffic by mTOR.
Found in translation of mTOR signaling.
mTOR inhibitors in cancer therapy.